ATENTIE! ACEASTA ANALIZA S-A FACUT DE MAI MULT DE mai mult de 4 ani!
Inregistreaza-te sau conecteaza-te pentru actualizarea analizei!
audit SEO : aperus.navinetsolutions.com
Bela Nagy
Partner
Instrumente mobile
Vizualizare mobil
Pagina web apare bine pe platforma mobila!
Vizualizare Tableta
Pagina web apare cu succes pe tableta!
Aparitie mobil
Optimizare mobil
Icoana Apple
Eticheta Meta viewport (pt instrumente mobile)
Continut flash
Vizualizare lista de cautare Google
Vizualizare Google
Aperus Pharma
aperus.navinetsolutions.com/
Atentie! Lipsa parte "meta description" : pagina nu are descriere cuprins!
Atentie! Lipsa parte "meta description" : pagina nu are descriere cuprins!
Domain / URL audit
Url
Domain : aperus.navinetsolutions.com/
Lungime (in caractere) : 28
Lungime (in caractere) : 28
Alexa
In baza de date Alexa nu sunt destule date despre pagina.
Control IP
104.27.180.3 adresa ip nu este pe lista spam
Audit SEO : analiza cuprins
Limba
Locatie de limbaj specificata: "en".
Titlu (Title)
Aperus Pharma
Lungime (in caractere) : 13
Minunat! Lungimea titlului paginii (Title) este intre 10 si 70 caractere.
Minunat! Lungimea titlului paginii (Title) este intre 10 si 70 caractere.
Raport text / cod
Raport : 6%
Eroare! Raportul text/cod pe pagina este sub procentul de 15 la suta. Asta arata, ca pagina are continut mic de text.
Eroare! Raportul text/cod pe pagina este sub procentul de 15 la suta. Asta arata, ca pagina are continut mic de text.
Flash
Minunat! Pagina nu foloseste flash.
Cadru
Splendid! Pagina nu foloseste solutie frame.
Cuvinte-cheie Cloud
page
overview
read
news
pharma
home
amyloid
solution
effects
email
committee
action
investors
neuronal
pipeline
memory
signalling
scientific
structure
company
granted
mechanisms
molecule
abeta
family
unique
clinical
protected
diseases
restores
r&d
all
history
drug
strategy
project
cells
aperus
neurodegenerative
alzheimer’s
marketing
against
disease
data-separator=yes
process
patent
business
candidate
approach
team
multiple
top
intellectual
property
partners
learn
Folosirea corespunzatoare a cuvintelor-cheie
| Cuvant-cheie | Continut | Titlu (Title) | Descriere (meta description) | Antete (Headinguri) |
|---|---|---|---|---|
| disease | 9 | |||
| alzheimer’s | 7 | |||
| candidate | 7 | |||
| aperus | 6 | |||
| drug | 5 | |||
| pharma | 5 |
| Cuvinte cheie (2 cuvinte) | Continut | Titlu (Title) | Descriere (meta description) | Antete (Headinguri) |
|---|---|---|---|---|
| alzheimer’s disease | 5 | |||
| project overview | 2 | |||
| learn more | 2 | |||
| pipeline scientific | 2 | |||
| candidate intellectual | 2 | |||
| strategy news | 2 |
| Cuvinte cheie (3 cuvinte) | Continut | Titlu (Title) | Descriere (meta description) | Antete (Headinguri) |
|---|---|---|---|---|
| clinical drug candidate | 2 |
Antete (Headinguri)
| H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | 2 | 3 | 3 | 2 | 6 |
Eroare. Din H1 este mai mult, decat 1
Structura Heading in codul de sursa
- <H6> About us
- <H2> Who We Are
- <H4> Company
- <H4> Project
- <H4> Drug candidate Q134R
- <H6> Q134R – Mechanisms of Action
- <H1>
- <H1> Q134R – Mechanisms of Action
- <H6> Q134R is a strong cytoprotective agent: at nanomolecular range, it protects neuronal cells against ROS- (reactive oxygen species) and Abeta- (amyloid beta) induced neuronal death, and restores mitochondrial functioning.
- <H6> Q134R restores memory impairment caused by scopolamine or Abeta oligomers, by modulation of the GABAA gated Cl- channels, specific for extrasynaptic signalling in neurogliaform cells, belonging to a specialized type of interneurons, which modulates memory formation.
- <H6> Q134R has inhibitory effects on NFATs: a family of calcineurin- (CN) dependent transcription factors linked to the multiple pathologic hallmarks that emerge during AD. Numerous studies show that inhibition of CN/NFAT signalling leads to beneficial effects on amyloid pathology, neuroinflammation, neuronal viability, synaptic physiology, and cognitive function in mouse models of AD.
- <H6> from the blog
- <H2> Our latest News
- <H3> Avidin Publishes in Molecules the Enantioselective Synthesis of 8-Hydroxyquinoline Derivative, Q134 Which is a Hypoxic Adaptation Inducer
- <H3> Unique Drug Candidate Being Developed Against Alzheimer’s Disease Reported by PharmaOnline
- <H3> New Patent Granted in USA
- <H5> Contact Us
- <H5> Follow Us
- Arata restul
Poze
Total 9 poze pe pagina web
Eticheta "alt" de mai jos 6 nu este completata pe pagina.
Cat de repede trebuie completata, ca motoarele de cautare sa poate defini pozele mai bine.
Eticheta "alt" de mai jos 6 nu este completata pe pagina.
Cat de repede trebuie completata, ca motoarele de cautare sa poate defini pozele mai bine.
audit SEO : Linkuri
URL SEO friendly
Minunat! Pagina foloseste URL-uri SEO friendly!
Subliniere URL
Minunat! Nu exista subliniere (_) in URL-uri.
Linkuri
Am gasit in total 46 linkuri diferite.
Numar linkuri interioare: 46
Numar linkuri interioare: 46
audit SEO: tehnologia
Directionare (www/ nu www)
Eroare! Adresa de web disponibila si in versiunea cu www si fara www!
Favicon
Minunat! Pagina foloseste favicon.
Doctype
HTML 5
Codificare
Perfect! UTF-8, codarea de caractere reglata.
Cod HTML invechit
Minunat! Nu exista solutii HTML invechite.
Imprimabilitate
Eroare! Pagina nu contine CSS, ce ajuta la imprimat.
Pagina 404
Site-ul dispune pagina 404 standard
Control robots.txt
Exista fisier robots.txt
https://aperus.navinetsolutions.com/robots.txt
https://aperus.navinetsolutions.com/robots.txt
| User-agent | Disallow (pagini interzise pt motoare de cautare) |
|---|---|
| * |
|
Harta site-ului
Lipsa harta site-ului!
Google Analytics
Pagina nu dispune de Google Analytics.
Management etichetelor Google
Pagina nu foloseste etichete Google.
E-mail privat
Minunat! Adrese de e-mailuri secrete!